The Skeletal Dysplasia Market is expanding, driven by advancements in gene sequencing and orphan drug incentives. Key ...
A man who has a rare bone disorder is being treated with a new therapy for the condition at the hospital where he also works. Neville Owens, 57, from Oswestry, Shropshire, has had X-linked ...
As with other drugs, Injectafer (ferric carboxymaltose) can cause side effects, such as nausea, high blood pressure, and flushed skin. If the side effects of Injectafer become difficult to tolerate, ...
This publication was sponsored by Daiichi Sankyo, Inc. Real-world data suggest that high-dose formulation ferric carboxymaltose injection (Injectafer; Daiichi Sankyo, Inc) may be a more cost-effective ...
In a patient with chronic renal disease and uremia who was under treatment with a low-protein diet, hemodialysis and aluminum hydroxide gel marked hypophosphatemia associated with anorexia, nausea, ...
XLH ("X" denotes X-chromosome, a sex-determining chromosome) is a rare bone disease characterised by hypophosphatemia (i.e., low phosphate in blood). It is caused by a mutation in the phosphate ...
HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong ...
Findings from UK burosumab early access program spotlighted in oral presentation at ASBMR annual meeting Statistically significant improvements seen in patient-reported measures of pain, stiffness, ...
One oral presentation and nine posters will shed light on real-world experiences of people living with XLH and the impact of burosumab treatment "As we learn more about XLH and how it impacts people's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results